Cargando…
BTF3 Silencing Inhibits the Proliferation of Osteosarcoma Cells
Osteosarcoma (OS) is one of the bone malignancy cancers with poor prognosis in the early stages worldwide. Basic transcription factor 3 (BTF3) is associated with the development of several types of cancer. The present study aimed to evaluate the role of BTF3 in OS. Silencing of BTF3 was achieved by...
Autores principales: | Liu, Qi, Jiang, Lin, Wang, Wanchun, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547992/ https://www.ncbi.nlm.nih.gov/pubmed/31205542 http://dx.doi.org/10.7150/jca.28476 |
Ejemplares similares
-
BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1
por: Wang, Peng, et al.
Publicado: (2023) -
Upregulation of long noncoding RNA Xist promotes proliferation of osteosarcoma by epigenetic silencing of P21
por: Xu, Tianyang, et al.
Publicado: (2017) -
Silencing of carboxypeptidase E inhibits cell proliferation, tumorigenicity, and metastasis of osteosarcoma cells
por: Fan, Shuli, et al.
Publicado: (2016) -
Rhotekin 2 silencing inhibits proliferation and induces apoptosis in human osteosarcoma cells
por: Wang, Xiong, et al.
Publicado: (2018) -
BTF measurements with beam-beam interactions
por: Gorgen, P., et al.
Publicado: (2014)